Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colesevelam vs Rosiglitazone or Sitagliptin in T2DM on Metformin
NCT00484419Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- May 2007
- Primary completion
- Apr 2008
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of colesevelam in type 2 diabetes mellitus (T2DM), hyperlipidemia, sponsored by Daiichi Sankyo Co., Ltd.. Started May 2007; status: completed.
02
Drugs
colesevelam
03
Conditions
type 2 diabetes mellitus (T2DM)hyperlipidemia
Beyond the preview
Go deeper on NCT00484419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00484419.